Cytokine genes single nucleotide polymorphism (SNP) screening analyses in canine malignant histiocytosis

Anticancer Research

Volumn 26, Issue 5 A, 2006, Pages 3417-3420

  Soller, Jan Thies ^a,b   Escobar, Hugo Murua ^a,b   Janssen, Miriam ^a   Fork, Melani ^b   Bullerdiek, Jörn ^a   Nolte, Ingo ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Bernese Mountain Dog (BMD); Canis familiaris; Cytokine genes; Malignant histiocytosis; Single nucleotide polymorphism

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; RNA; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CYTODIAGNOSIS; DOG; HISTOPATHOLOGY; MALIGNANT HISTIOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; RNA ISOLATION; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DNA, COMPLEMENTARY; DOGS; GENOTYPE; HISTIOCYTOSIS, MALIGNANT; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MASS SCREENING; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750739200     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tazi A, Soler P and Hance AJ: Adult pulmonary Langerhans' cell histiocytosis. Thorax 55(5): 405-416, 2000.
2. Kannourakis G and Abbas A: The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J Cancer Suppl 23: S37-40, 1994.
3. Ostrander EA, Galibert F and Patterson DF: Canine genetics comes of age. Trends Genet 16(3): 117-124, 2000.
4. Ostrander EA and Kruglyak L: Unleashing the canine genome. Genome Res 10(9): 1271-1274, 2000.
5. Patterson DF: Companion animal medicine in the age of medical genetics. J Vet Intern Med 14(1): 1-9, 2000.
6. Ramsey IK, McKay JS, Rudorf H and Dobson JM: Malignant histiocytosis in three Bernese mountain dogs. Vet Rec 138(18): 440-444, 1996.
7. Nolte I and Nolte M: Praxis der Onkologie bei Hund und Katze. Stuttgard, Enke Verlag, pp. 143-144, 2000.
8. Affolter VK and Moore PF: Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol 39(1): 74-83, 2002.
9. Egeler RM, Favara BE, van Meurs M, Laman JD and Claassen E: Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94(12): 4195-4201, 1999.
10. Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ and Soler P: Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 163(6): 3511-3515, 1999.
11. Arico M and Danesino C: Langerhans' cell histiocytosis: is there a role for genetics? Haematologica 86(10): 1009-1014, 2001.
12. Arico M: Langerhans cell histiocytosis: Too many cytokines, not enough gene regulation? Pediatr Blood Cancer 2006.
13. Stylianou E and Saklatvala J: Interleukin-1. Int J Biochem Cell Biol 30(10): 1075-1079, 1998.
14. Straubinger AF, Viveiros MM and Straubinger RK: Identification of two transcripts of canine, feline, and porcine interleukin-1 alpha. Gene 236(2): 273-280, 1999.
15. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87(6): 2095-2147, 1996.
16. Kobayashi Y, Yamamoto K, Saido T, Kawasaki H, Oppenheim JJ and Matsushima K: Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci USA 87(14): 5548-5552, 1990.
17. Stevenson FT, Bursten SL, Fanton C, Locksley RM and Lovett DH: The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece. Proc Natl Acad Sci USA 90(15): 7245-7249, 1993.
18. Priestle JP, Schar HP and Grutter MG: Crystal structure of the cytokine interleukin-1 beta. Embo J 7(2): 339-343, 1988.
19. Priestle JP, Schar HP and Grutter MG: Crystallographic refinement of interleukin 1 beta at 2.0 A resolution. Proc Natl Acad Sci USA 86(24): 9667-9671, 1989.
20. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ and Thompson RC: Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 88(12): 5232-5236, 1991.
21. Beutler B and Cerami A: The biology of cachectin/TNF - a primary mediator of the host response. Annu Rev Immunol 7: 625-655, 1989.
22. Dennis RA, Trappe TA, Simpson P, Carroll C, Huang BE, Nagarajan R, Bearden E, Gurley C, Duff GW, Evans WJ, Kornman K and Peterson CA: Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise. J Physiol 560(Pt 3): 617-626, 2004.
23. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F and Haugen A: Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109(3): 353-356, 2004.
24. Correa PA, Gomez LM, Cadena J and Anaya JM: Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32(2): 219-224, 2005.